NCT02700685View on ClinicalTrials.gov

Effect of Pycnogenol® on ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

November 20, 2020

Study Completion Date

November 20, 2020

Conditions
ADHD
Interventions
DIETARY_SUPPLEMENT

Pycnogenol

Dietary supplement, standardised extract of French maritime Pine bark. This group receives a nutritional supplement for a period of 10 weeks.

DRUG

Methylphenidate

Standard pharmaceutical treatment for ADHD, slow release.

OTHER

Placebo

Placebo treatment (identical capsules containing excipients only)

Trial Locations (3)

2650

University Hospital Antwerp, Edegem

9000

University Hospital Ghent, Ghent

Unknown

Universitaire Kinder- en Jeugdpsychiatrie, Borgerhout

All Listed Sponsors
lead

Nina Hermans

OTHER

NCT02700685 - Effect of Pycnogenol® on ADHD | Biotech Hunter | Biotech Hunter